Usefulness of serum albumin and serum total cholesterol in the prediction of hospital death in older patients with severe, acute heart failure.

[1]  Pierre Ambrosi,et al.  Human serum albumin in the clinical syndrome of heart failure. , 2011, Journal of cardiac failure.

[2]  A. Ferreira,et al.  Nutritional markers and prognosis in cardiac cachexia. , 2011, International journal of cardiology.

[3]  Toshihisa Hirai,et al.  Clinical outcomes and prognostic factor for acute heart failure in nonagenarians: impact of hypoalbuminemia on mortality. , 2010, International journal of cardiology.

[4]  S. Moore,et al.  Serum albumin and mortality in acutely decompensated heart failure. , 2010, American heart journal.

[5]  S. Kimmel,et al.  Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival , 2010, Circulation.

[6]  K. Kotani,et al.  A simple risk score to predict in-hospital death of elderly patients with acute decompensated heart failure--hypoalbuminemia as an additional prognostic factor. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[7]  B. Bart.  Treatment of congestion in congestive heart failure: ultrafiltration is the only rational initial treatment of volume overload in decompensated heart failure. , 2009, Circulation. Heart failure.

[8]  P. Ponikowski,et al.  Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. , 2008, European heart journal.

[9]  F. Ginsberg.  Timing of Immunoreactive B-Type Natriuretic Peptide Levels and Treatment Delay in Acute Decompensated Heart Failure: An ADHERE (Acute Decompensated Heart Failure National Registry) Analysis , 2009 .

[10]  C. Yancy,et al.  Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure. , 2008, American heart journal.

[11]  E. Bourdon,et al.  The antioxidant properties of serum albumin , 2008, FEBS letters.

[12]  P. Sbragia,et al.  Usefulness of serum albumin concentration for in-hospital risk stratification in frail, elderly patients with acute heart failure. Insights from a prospective, monocenter study. , 2008, International journal of cardiology.

[13]  C. Phillips,et al.  Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. , 2008, The American journal of cardiology.

[14]  F. Formiga,et al.  Hospitalization due to acute heart failure. Role of the precipitating factors. , 2007, International journal of cardiology.

[15]  C. Phillips,et al.  Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. , 2007, Journal of the American College of Cardiology.

[16]  C. Wiedermann.  Anti-inflammatory activity of albumin. , 2007, Critical care medicine.

[17]  Pablo Castro G,et al.  [Predictors of hospital death and prolonged hospitalization in patients with cardiac failure in Chilean hospitals]. , 2006, Revista medica de Chile.

[18]  C. Yancy,et al.  Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. , 2006, Journal of the American College of Cardiology.

[19]  H. Krumholz,et al.  Physician specialty and mortality among elderly patients hospitalized with heart failure. , 2005, The American journal of medicine.

[20]  William T. Abraham,et al.  Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis , 2005 .

[21]  H. Krumholz,et al.  Predictors of cardiologist care for older patients hospitalized for heart failure. , 2004, American heart journal.

[22]  J. Vincent,et al.  Hypoalbuminemia in Acute Illness: Is There a Rationale for Intervention?: A Meta-Analysis of Cohort Studies and Controlled Trials , 2003, Annals of surgery.

[23]  G. Bernard,et al.  Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury* , 2002, Critical care medicine.

[24]  Suzanne G. Leveille,et al.  The Value of Serum Albumin and High‐Density Lipoprotein Cholesterol in Defining Mortality Risk in Older Persons with Low Serum Cholesterol , 2001, Journal of the American Geriatrics Society.

[25]  G. Licata,et al.  Effects of high‐dose furosemide and small‐volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure , 2000, European journal of heart failure.

[26]  J. Ix,et al.  The Predictive Value of Combined Hypoalbuminemia and Hypocholesterolemia in High Functioning Community‐Dwelling Older Persons: MacArthur Studies of Successful Aging , 1999, Journal of the American Geriatrics Society.

[27]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[28]  C Safran,et al.  Serum albumin level on admission as a predictor of death, length of stay, and readmission. , 1992, Archives of internal medicine.

[29]  I. Hill,et al.  Effect of albumin on the electrophysiologic stability of isolated perfused rabbit hearts. , 1989, Journal of cardiovascular pharmacology.

[30]  L. D. Segel,et al.  Albumin improves stability and longevity of perfluorochemical-perfused hearts. , 1988, The American journal of physiology.